Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VYCOR MEDICAL INCVYCO · Entity 8497 | Director | March 31, 2021 | April 08, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VYCOR MEDICAL INC
Report date March 31, 2021 · Filed April 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Vycor Medical Inc. Common Stock par value $0.001SEC Table I · non-derivative | Direct | 594,985 |
Reported balance
After 2021-03-31 transaction · row 1
1 source rowRow 1 · 2021-03-31 · Other · Acquired 33,333 · Balance 594,985 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2021 Filed Apr 8, 2021 10:34 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-21-008265 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,985 Read SEC document |
| December 31, 2020 Filed Jan 11, 2021 20:22 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-21-000735 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,652 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| September 30, 2020 Filed Oct 6, 2020 21:18 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-20-019042 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,319 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| June 30, 2020 Filed Jul 8, 2020 01:36 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-20-012774 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,986 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| March 31, 2020 Filed Apr 7, 2020 10:15 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-20-005943 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,653 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| December 31, 2019 Filed Jan 7, 2020 11:06 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-20-000285 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,320 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| September 30, 2019 Filed Oct 9, 2019 18:52 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-19-015298 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,987 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:37 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-19-010156 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,654 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| March 31, 2019 Filed Apr 3, 2019 19:31 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-19-004818 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,321 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| December 31, 2018 Filed Jan 8, 2019 18:49 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-19-000306 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,988 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| September 30, 2018 Filed Oct 23, 2018 13:27 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 24,138 | $0.29 | $7,000.02 |
DisclosureSEC source: 0001493152-18-014771 · ownership.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,655 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| June 30, 2018 Filed Jul 10, 2018 10:10 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 21,212 | $0.33 | $6,999.96 |
DisclosureSEC source: 0001493152-18-009842 · form4.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,517 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| March 31, 2018 Filed Apr 4, 2018 17:12 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 14,583 | $0.48 | $6,999.84 |
DisclosureSEC source: 0001493152-18-004741 · form4.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,305 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 17:48 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 18,919 | $0.37 | $7,000.03 |
DisclosureSEC source: 0001493152-18-000083 · form4.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,722 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| September 30, 2017 Filed Oct 6, 2017 19:10 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 25,000 | $0.28 | $7,000.00 |
DisclosureSEC source: 0001493152-17-011377 · form4.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,803 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| June 30, 2017 Filed Jul 21, 2017 19:39 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-17-008080 · form4.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,803 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. F2 · balance_after: Includes an adjustment of 300 shares based upon a calculation error in the reporting person's report as of December 31, 2016. Read SEC document |
| March 31, 2017 Filed Apr 6, 2017 19:51 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-17-003584 · form4.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,170 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| December 31, 2016 Filed Jan 13, 2017 19:04 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 21,212 | $0.33 | $6,999.96 |
DisclosureSEC source: 0001493152-17-000452 · form4.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,837 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| September 30, 2016 Filed Oct 7, 2016 17:56 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 20,588 | $0.34 | $6,999.92 |
DisclosureSEC source: 0001354488-16-008369 · issuerdirect_section16.xml · nonDerivative · entry 1 Rush Lowell · CIK 0001595155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,925 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.